Literature DB >> 21406151

Old drugs, new uses.

Marcio A da Fonseca1, Paul Casamassimo.   

Abstract

Advances in pediatric health care have prolonged lives and improved the quality of life for children and adolescents. These advances include not only high-tech devices and new medications but also re-application of available medications to take advantage of unexpected benefits which may not have been known previously or even side effects that can have therapeutic value for diseases and conditions refractory to other treatment. This review describes new uses for anti-epileptic medications, thalidomide, intravenous immunoglobulin, hydroxyurea, methotrexate, botulinum toxin, bisphosphonates, and aspirin in the medical care of children. Methods of action and concerns for the pediatric dentist are described for children benefiting from these new applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21406151

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  4 in total

1.  RAD53 is limiting in double-strand break repair and in protection against toxicity associated with ribonucleotide reductase inhibition.

Authors:  Shay Covo; James W Westmoreland; Amit K Reddy; Dmitry A Gordenin; Michael A Resnick
Journal:  DNA Repair (Amst)       Date:  2012-01-23

2.  Preclinical efficacy of melatonin to reduce methotrexate-induced oxidative stress and small intestinal damage in rats.

Authors:  Viswa Kalyan Kolli; Premila Abraham; Bina Isaac; N Kasthuri
Journal:  Dig Dis Sci       Date:  2012-10-10       Impact factor: 3.199

3.  Growth effects of botulinum toxin type A injected unilaterally into the masseter muscle of developing rats.

Authors:  Chanyoung Park; Kitae Park; Jiyeon Kim
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066

4.  Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs).

Authors:  Ivan Molineris; Ugo Ala; Paolo Provero; Ferdinando Di Cunto
Journal:  BMC Bioinformatics       Date:  2013-10-02       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.